Links
Administrative simplicity vs. single payer. 340B case heads to the Supreme Court. Marketing and mammograms NY ends state of emergency: what happens to out-of-state licensed health care professionals? Key facts on the Delta Variant.
Author: Jason Shafrin
MedPAC report on alternative payment models
In 2021, CMS expects to operate 12 alternative payment models (APMs) offering 25 distinct tracks for providers to choose from that involve different payment options and risk arrangement… providers serving about 20 percent of Medicare beneficiaries participate in this APM That is a quote from a June 2021 MedPAC report on CMS APM’s serving Medicare…
Economic Analysts: FTI Consulting Ranked #1
FTI Consulting was ranked #1 in the global Economic Analysts category for Chambers Litigation Support Guide 2021. Congratulations to the entire FTI team!
COVID-19 in California: An update
A few updates on COVID-19 from where I am living. First while we see a dramatic decline in COVID-19 infections and deaths, there is a fair amount of regional variation within California. The Sacramento Bee reports that: The average number of new COVID infections reported each day dropped by an astounding 98% from December to…
Few Americans research hospital prices
New regulation is making hospital prices available to patients. The Kaiser Family Foundation (KFF) reports: As of January 1 of this year, hospitals are required to post prices of common health services on their websites via consumer-friendly tools for patient use. Prior to implementation of this rule, hospitals were only required to publish their gross,…
How easy is it for patients to access cell and gene therapies in Europe?
Cell and gene therapies have the potential to produce dramatic improvements in quality of life and survival for severe and often rare diseases. Currently, however, the cost of these treatments is high and access is sometimes limited. To identify some of these challenges in Europe EURODIS conducted an evaluation of country-specific challenges with respect to…
Links
Evaluating the robustness of CMS Hospital VBP measurement system. ICER’s gene therapy evaluations. Who are high-frequency hospital users? EHR and malpractice. What is Evio? Has in vivo gene editing come of age?
Do most Medicare Part D drugs have CEA studies?
That is the question that a recent study by Tisdale et al. (2021) aim to answer. They first look at the top 250 Medicare Part D drugs in terms 2016 total spending based on the 2016 Medicare Part D Prescriber Public Use File. Drug characteristics were identified from the 2016 FDA Orange Book. The authors…
Intellectual Property Rights and Innovation
That is the title of a 2016 NBER chapter by Heidi Williams and the subtitle is “Evidence from Health Care Markets“. Economic theory back to Nordhaus (1969) predicts that intellectual property rights increase the incentive for firms to invest in research and development and likely this would lead to more innovation. Proving these empirically, however,…
Job security and health: An asymmetric impact
COVID-19 has increased job insecurity for many workers around the world. At the same time, after vaccinations, job growth is slowly coming back. Will increased job security undo deleterious impacts of previous job insecurity worries? An interesting finding from Lepinteur (2021) weighs in on the topic: Is workers’ health more sensitive to losses than gains…